RBM22 and cancer: Additionally, the apoptosis inhibitor Z-VAD-FMK, but not the autophagy inhibitor 3-MA, rescued cancer cell viability, demonstrating that RBM22 is involved in apoptosis rather than autophagy (Figure 2B).